Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Budgeting aids success by clarifying priorities, reducing waste, and creating a roadmap toward your desired financial outcomes.
19,451 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Can one stock turn you into a millionaire? This guide examines Micron stock, the real-world math of wealth, and smart...
When life tests a family, money becomes a shared tool. This article draws on the idea behind john stamos says family ...
A Microsoft AI diffusion report reveals AI usage climbing across all states, with Texas outpacing California and nont...
After a two-week export-control standoff, Anthropic’s most powerful AI models are back online. The settlement restore...
Former Google CEO Eric Schmidt highlights a tension between competitiveness and work-life balance as U.S. firms face ...
As KB unveils its Q1 2026 results, investors will parse revenue signals, margin dynamics, and guidance. This guide br...
A quiet pivot is reshaping a once purely crypto-focused business. This former bitcoin miner is transitioning into AI-...
A cruise stock jumps as an activist investor takes a stake, signaling potential governance shifts. This article break...
Investors want to know where will amazon stock head in three years. This article breaks down AWS growth, AI investmen...
Rivian faces a challenging journey into 2026, with big questions about profitability, demand, and policy shifts. This...
C3.AI stock has shed shares in 2026, but that drop raises the question: is this a buying opportunity or a trap? This ...